|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net (loss)/income | |||||
| Adjustments to reconcile net (loss)/income to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use assets | |||||
| Share-based compensation expenses | |||||
| Loss/(gain) on short-term investments | |||||
| Impairment loss for property, plant and equipment | |||||
| Impairment loss for goodwill | |||||
| Impairment loss for long-term equity investment | |||||
| Impairment loss for equity method investments | |||||
| Allowance (Reversal of allowance) for doubtful accounts | |||||
| Share of (profit)/loss from equity method investees, net of income tax | |||||
| Provision of allowance for credit losses | |||||
| Accounts payable write-off benefit | |||||
| Amounts due to related parties write-off benefit | |||||
| Property, plant and equipment written off | |||||
| Loss on disposal of property, plant and equipment | |||||
| Foreign currency exchange (gain)/loss | |||||
| Gain on acquisition of subsidiaries | |||||
| Gain on disposal of subsidiaries | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Amounts due from related parties | |||||
| Prepayments and other assets | |||||
| Inventories | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Amounts due to related parties | |||||
| Customers’ refundable fees | |||||
| Accrued expenses and other payables | |||||
| Lease liabilities | |||||
| Income tax payables | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment | |||||
| Prepayment for acquisition of property | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Investment in equity method investees | |||||
| Return of capital from equity method investees | |||||
| Cash received from/(paid for) acquisition of subsidiaries, net of cash acquired | |||||
| Cash advances made to related parties | |||||
| Cash received from/(paid for) disposal of subsidiaries | |||||
| Cash paid for short-term investments | |||||
| Proceeds from disposal of short-term investments | |||||
| Net cash provided by/(used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of ordinary shares, net of issuance costs | |||||
| Contribution from non-controlling shareholders | |||||
| Proceeds from issuance of convertible promissory note, net of issuance costs | |||||
| Proceeds from regular warrants exercised | |||||
| Proceeds from issuance and exercise of pre-funded warrants | |||||
| Repayment for short-term bank borrowings | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, cash equivalents and restricted cash at the end of the year | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Cash paid for amounts include in lease liabilities | |||||
| Supplemental disclosure of non-cash flow information | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Issuance of convertible promissory note for intangible asset purchase | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...